amrinone has been researched along with propranolol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (26.09) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Janz, TG; Leasure, JA; Love, JN; Mundt, DJ | 1 |
| Junkin, P; Riley, CM | 1 |
| Brilla, C; Jacob, R; Kissling, G; Vogt, M | 1 |
| Kapur, PA; Makela, VH | 1 |
| Alousi, AA; Canter, JM; Fort, DJ | 1 |
| Einzig, S; Kulik, TJ; Lock, JE; Mammel, MC; Thompson, TR | 1 |
| Aronson, RS; Hertzberg, J; Nusrat, A; Sonnenblick, EH; Tepper, D | 1 |
| Adams, HR; Rhody, J; Sutko, JL | 1 |
| Leasure, JA; Love, JN; Mundt, DJ | 1 |
| Alleva, FR; Balazs, T; Joseph, X; Vick, JA; Whitehurst, VE; Zhang, J | 1 |
1 review(s) available for amrinone and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
22 other study(ies) available for amrinone and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model.
Topics: Amrinone; Animals; Cardiovascular Diseases; Depression, Chemical; Dogs; Drug Overdose; Electrocardiography; Glucagon; Hemodynamics; Propranolol; Random Allocation | 1992 |
Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
Topics: Amrinone; Bicarbonates; Chromatography, High Pressure Liquid; Digoxin; Drug Combinations; Drug Incompatibility; Drug Stability; Potassium Chloride; Procainamide; Propranolol; Sodium; Sodium Bicarbonate; Verapamil | 1991 |
Haemodynamic effects of amrinone in the anaesthetized pig.
Topics: Amrinone; Animals; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Myocardial Contraction; Propranolol; Stroke Volume; Swine; Vasodilation | 1988 |
Amrinone and verapamil-propranolol induced cardiac depression during isoflurane anesthesia in dogs.
Topics: Amrinone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Dogs; Drug Interactions; Heart; Isoflurane; Propranolol; Verapamil | 1987 |
The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Central Venous Pressure; Dogs; Female; Heart Failure; Male; Pentobarbital; Procainamide; Propranolol; Vascular Resistance; Verapamil | 1985 |
Pulmonary vascular effects of amrinone in conscious lambs.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Female; Hypoxia; Male; Propranolol; Pulmonary Circulation; Sheep; Vascular Resistance; Vasodilation | 1983 |
Effects of amrinone on atrioventricular conduction in the intact canine heart.
Topics: Aminopyridines; Amrinone; Animals; Bundle of His; Cardiotonic Agents; Dogs; Heart Conduction System; Ouabain; Propranolol; Sinoatrial Node; Verapamil | 1983 |
Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Guinea Pigs; Heart Atria; Heart Ventricles; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Phentolamine; Potassium; Propranolol; Stimulation, Chemical | 1982 |
A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model.
Topics: Amrinone; Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Depression, Chemical; Dogs; Drug Therapy, Combination; Glucagon; Heart Rate; Hypotension; Propranolol | 1993 |
Reversal of propranolol blockade of adrenergic receptors and related toxicity with drugs that increase cyclic AMP.
Topics: Adenylyl Cyclases; Adrenergic Antagonists; Aminophylline; Amrinone; Animals; Blood Pressure; Cardiovascular Diseases; Colforsin; Cyclic AMP; Dogs; Enzyme Activation; Heart Rate; Myocardium; Phosphodiesterase Inhibitors; Propranolol; Respiration | 1999 |